These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 26354055)

  • 21. Prevalence of masked hypertension in attended versus unattended office blood pressure measurement.
    Bertram S; Bauer F; Shadi R; Seidel M; Doevelaar A; Seibert F; Babel N; Westhoff TH
    J Clin Hypertens (Greenwich); 2024 Jun; 26(6):615-623. PubMed ID: 38751130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic accuracy of home vs. ambulatory blood pressure monitoring in untreated and treated hypertension.
    Nasothimiou EG; Tzamouranis D; Rarra V; Roussias LG; Stergiou GS
    Hypertens Res; 2012 Jul; 35(7):750-5. PubMed ID: 22357523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Home blood pressure measurement in prehypertension and untreated hypertension: comparison with ambulatory blood pressure monitoring and office blood pressure.
    Zhuo S; Wen W; Li-Yuan M; Shu-Yu W; Yi-Xin W
    Blood Press Monit; 2009 Dec; 14(6):245-50. PubMed ID: 19918171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse prognostic value of persistent office blood pressure elevation in white coat hypertension.
    Mancia G; Facchetti R; Grassi G; Bombelli M
    Hypertension; 2015 Aug; 66(2):437-44. PubMed ID: 26056342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognosis of Masked and White Coat Uncontrolled Hypertension Detected by Ambulatory Blood Pressure Monitoring in Elderly Treated Hypertensive Patients.
    Pierdomenico SD; Pierdomenico AM; Coccina F; Porreca E
    Am J Hypertens; 2017 Nov; 30(11):1106-1111. PubMed ID: 29059303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis of Pediatric Hypertension: European Society of Hypertension-Recommended 24-Hour vs. 24-Hour-Day-Night Ambulatory Blood Pressure Thresholds.
    Sharma AP; Norozi K; Grattan M; Filler G; Altamirano-Diaz L
    Am J Hypertens; 2021 Mar; 34(2):198-206. PubMed ID: 33011756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Masked hypertension assessed by ambulatory blood pressure versus home blood pressure monitoring: is it the same phenomenon?
    Stergiou GS; Salgami EV; Tzamouranis DG; Roussias LG
    Am J Hypertens; 2005 Jun; 18(6):772-8. PubMed ID: 15925734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short-term variability and nocturnal decline in ambulatory blood pressure in normotension, white-coat hypertension, masked hypertension and sustained hypertension: a population-based study of older individuals in Spain.
    Gijón-Conde T; Graciani A; López-García E; Guallar-Castillón P; García-Esquinas E; Rodríguez-Artalejo F; Banegas JR
    Hypertens Res; 2017 Jun; 40(6):613-619. PubMed ID: 28179625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical correlates of ambulatory BP monitoring among patients with CKD.
    Iimuro S; Imai E; Watanabe T; Nitta K; Akizawa T; Matsuo S; Makino H; Ohashi Y; Hishida A;
    Clin J Am Soc Nephrol; 2013 May; 8(5):721-30. PubMed ID: 23411432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of olmesartan-based treatment on home and clinic blood pressure in elderly patients with masked and white coat hypertension.
    Kushiro T; Kario K; Saito I; Teramukai S; Mori Y; Okuda Y; Shimada K
    Hypertens Res; 2015 Mar; 38(3):178-85. PubMed ID: 25354777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. White-coat effect and masked hypertension in patients with high-normal office blood pressure: results of the Hungarian ABPM Registry.
    Nemcsik J; Takács J; Kekk Z; Farsang C; Simon A; Páll D; Torzsa P; Dolgos S; Habony N; Koller Á; Pásztor D; Járai Z
    J Hypertens; 2024 Nov; 42(11):1976-1984. PubMed ID: 39222067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of blood pressure profile in chronic hemodialysis patients using two measurement methods: Home blood pressure measurement and conventional measurement.
    Faye M; Faye M; Lemrabott AT; Cisse MM; Fall K; Ismael Keita AR; Mbengue M; Ba B; Keita N; Diagne S; Niang A; Diouf B; Ka EHF
    Saudi J Kidney Dis Transpl; 2019; 30(5):1038-1043. PubMed ID: 31696841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood Pressure Measurement and Treatment Decisions.
    Kario K; Thijs L; Staessen JA
    Circ Res; 2019 Mar; 124(7):990-1008. PubMed ID: 30920932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Setting thresholds to varying blood pressure monitoring intervals differentially affects risk estimates associated with white-coat and masked hypertension in the population.
    Asayama K; Thijs L; Li Y; Gu YM; Hara A; Liu YP; Zhang Z; Wei FF; Lujambio I; Mena LJ; Boggia J; Hansen TW; Björklund-Bodegård K; Nomura K; Ohkubo T; Jeppesen J; Torp-Pedersen C; Dolan E; Stolarz-Skrzypek K; Malyutina S; Casiglia E; Nikitin Y; Lind L; Luzardo L; Kawecka-Jaszcz K; Sandoya E; Filipovský J; Maestre GE; Wang J; Imai Y; Franklin SS; O'Brien E; Staessen JA;
    Hypertension; 2014 Nov; 64(5):935-42. PubMed ID: 25135185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Cardiovascular Risk of White-Coat Hypertension.
    Franklin SS; Thijs L; Asayama K; Li Y; Hansen TW; Boggia J; Jacobs L; Zhang Z; Kikuya M; Björklund-Bodegård K; Ohkubo T; Yang WY; Jeppesen J; Dolan E; Kuznetsova T; Stolarz-Skrzypek K; Tikhonoff V; Malyutina S; Casiglia E; Nikitin Y; Lind L; Sandoya E; Kawecka-Jaszcz K; Filipovský J; Imai Y; Wang JG; O'Brien E; Staessen JA;
    J Am Coll Cardiol; 2016 Nov; 68(19):2033-2043. PubMed ID: 27810041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of Masked and White-Coat Hypertension in Pre-Hypertensive and Stage 1 Hypertensive patients with the use of TeleMRPA.
    Barroso WKS; Feitosa ADM; Barbosa ECD; Miranda RD; Brandão AA; Vitorino PVO; Ribeiro LPS; Gomes MM
    Arq Bras Cardiol; 2019 Nov; 113(5):970-975. PubMed ID: 31432980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence, determinants, and clinical significance of masked hypertension and white-coat hypertension in patients with chronic kidney disease.
    Tang H; Gong WY; Zhang QZ; Zhang J; Ye ZC; Peng H; Wang C; Lou T
    Nephrology (Carlton); 2016 Oct; 21(10):841-50. PubMed ID: 26566951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ambulatory blood pressure measurement in the main cities of Cameroon: prevalence of masked and white coat hypertension, and influence of body mass index.
    Takah N; Dzudie A; Ndjebet J; Wawo G; Kamdem F; Monkam Y; Luma H; Ngu KB; Kengne AP
    Pan Afr Med J; 2014; 19():240. PubMed ID: 25848455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Target Organ Complications and Cardiovascular Events Associated With Masked Hypertension and White-Coat Hypertension: Analysis From the Dallas Heart Study.
    Tientcheu D; Ayers C; Das SR; McGuire DK; de Lemos JA; Khera A; Kaplan N; Victor R; Vongpatanasin W
    J Am Coll Cardiol; 2015 Nov; 66(20):2159-2169. PubMed ID: 26564592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of white-coat and masked hypertension in national and international registries.
    Gorostidi M; Vinyoles E; Banegas JR; de la Sierra A
    Hypertens Res; 2015 Jan; 38(1):1-7. PubMed ID: 25319601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.